Activin signaling inhibitor Sotatercept in pulmonary veno-occlusive disease: building a bridge to transplantation?
Background: Pulmonary veno-occlusive disease (PVOD) is a rare form of pulmonary arterial hypertension (PAH). Its prognosis is considerably worse and no medical treatment has a proven efficacy. Vasodilating drugs for PAH may contribute to a pulmonary edema in PVOD. Sotatercept is the latest approved...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2026-01-01
|
| Serie: | Respiratory Medicine Case Reports |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2213007126000857 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|